Whereas, the vast majority of studies have shown overexpression of CLDNs 3 and -4, levels of OCLN and JAM-A TJ membrane proteins have been found to be decreased in endometrial cancer 15-16. The gene discussed is OCLN; the disease is endometrial cancer.